Unverified50% confidenceEventExact time
In November 2024, Recursion acquired Exscientia for $688 million in stock, and the combined company says it has more than 10 clinical and preclinical programs.
1
Sources
50%
Confidence
Long-term
Relevance
10/17/2026
First Seen
Sources
Related Entities
Related Claims
Cite This Claim
Stable URI
https://kongchang.com/claim/1055124API
curl https://kongchang.com/api/v1/knowledge/claims/1055124MCP
get_claim(id=1055124)